Cannabis Sativa

Sir John Savill
Born
John Stewart Savill

(1957-04-25) 25 April 1957 (age 66)[2]
Alma materUniversity of Oxford (BA)[2]
University of Sheffield (MB ChB)
Royal Postgraduate Medical School (PhD)
Awards
Scientific career
FieldsMedicine
Immunology
Apoptosis
InstitutionsHammersmith Hospital
University of Edinburgh
Medical Research Council
University of Oxford
University of Sheffield
ThesisMacrophage recognition of senescent neutrophils (1989)
Websitemrc.ac.uk/about/chief-executive-management-board/

Sir John Stewart Savill, FRS,[1] FMedSci (born 25 April 1957)[2] is the Chief Executive of the Medical Research Council (MRC) in the UK and the Head of the College of Medicine and Veterinary Medicine and a Vice Principal of the University of Edinburgh.[3]

Education[edit]

Savill was educated at St Catherine's College, Oxford and the University of Sheffield[2] where he gained his Bachelor of Medicine, Bachelor of Surgery in 1981 Savill was awarded a PhD for his work on macrophages from the Royal Postgraduate Medical School in 1989.[4]

Research and career[edit]

Savill is widely known for his research is on apoptosis and immunology.[5][6][7][8] As of 2016 Savill is active in acute general medicine and is an Honorary Consultant Physician and Nephrologist with the Lothian University Hospitals Division. He is a member of the Lothian Health Board and chairs its Service Redesign Committee.

Savill has extensive experience in peer review and has a particular interest in research and development, and the career structures necessary for this, having chaired the Academy of Medical Sciences Working Party on Clinical Academic Careers.

John Savill's research interests revolve around the role of cell death and macrophages in resolution and repair of inflammation, especially inflammatory disorders of the kidney glomerulus (glomerulonephritis) and interstitium (tubulointerstitial nephritis).

Present [when?] roles[edit]

  • Vice Principal and Head of the College of Medicine and Veterinary Medicine at the University of Edinburgh since October 2002.
  • Professor of Experimental Medicine since 1998.
  • Chair of Medicine since 1998
  • Chairman of the Physiological Systems and Clinical Sciences Board of the MRC, and is a full member of the Council itself.
  • Chief Executive of the Medical Research Council UK since 1 October 2010.[9] As of 2015, Savill was paid a salary of between £170,000 and £174,999 by the MRC, making him one of the 328 most highly paid people in the British public sector at that time.[10]

Previous roles[edit]

  • Director of the Medical Research Council (MRC) and University of Edinburgh Centre for Inflammation Research, where he continues to direct a group interested in the molecular cell biology of renal inflammation.
  • Professor of Medicine since 1998, a role he vacated in 1998.

Awards and honours[edit]

He was appointed Knight Bachelor in the 2008 New Year Honours.[11] He was also elected a Fellow of the Royal Society (FRS) in 2013,[1] awarded Fellowship of the Royal College of Physicians (FRCP),[when?] elected a Fellow of the Academy of Medical Sciences (FMedSci) [when?] and a Fellow of the Royal Society of Edinburgh (FRSE).[when?] He is an honorary member of the British Society for Immunology.[12] In 1999 he was elected a member of the Harveian Society of Edinburgh and in 2009 he served as President of the Society.[13] He was elected a Fellow of the Australian Academy of Health and Medical Sciences in 2021.[14]

References[edit]

  1. ^ a b c Anon (2013). "Sir John Savill FMedSci FRS". London: royalsociety.org. Archived from the original on 17 November 2015. One or more of the preceding sentences incorporates text from the royalsociety.org website where:

    "All text published under the heading 'Biography' on Fellow profile pages is available under Creative Commons Attribution 4.0 International License." --"Royal Society Terms, conditions and policies". Archived from the original on 25 September 2015. Retrieved 9 March 2016.{{cite web}}: CS1 maint: bot: original URL status unknown (link)

  2. ^ a b c d "SAVILL, Sir John Stewart". Who's Who. Vol. 2013 (online Oxford University Press ed.). Oxford: A & C Black. (Subscription or UK public library membership required.)
  3. ^ John Savill publications indexed by Microsoft Academic
  4. ^ Savill, John (1989). Macrophage recognition of senescent neutrophils (PhD thesis). Royal Postgraduate Medical School. OCLC 940323102.(subscription required)
  5. ^ Savill, J.; Fadok, V.; Henson, P.; Haslett, C. (1993). "Phagocyte recognition of cells undergoing apoptosis". Immunology Today. 14 (3): 131–136. doi:10.1016/0167-5699(93)90215-7. PMID 8385467.
  6. ^ Savill, J.; Dransfield, I.; Gregory, C.; Haslett, C. (2002). "A blast from the past: Clearance of apoptotic cells regulates immune responses". Nature Reviews Immunology. 2 (12): 965–975. doi:10.1038/nri957. PMID 12461569.
  7. ^ Savill, J.; Fadok, V. (2000). "Corpse clearance defines the meaning of cell death". Nature. 407 (6805): 784–788. Bibcode:2000Natur.407..784S. doi:10.1038/35037722. PMID 11048729. S2CID 4410310.
  8. ^ Savill, J. S.; Wyllie, A. H.; Henson, J. E.; Walport, M. J.; Henson, P. M.; Haslett, C. (1989). "Macrophage phagocytosis of aging neutrophils in inflammation. Programmed cell death in the neutrophil leads to its recognition by macrophages". Journal of Clinical Investigation. 83 (3): 865–875. doi:10.1172/JCI113970. PMC 303760. PMID 2921324.
  9. ^ "New MRC Chief Executive announced". Archived from the original on 4 January 2013. Retrieved 30 November 2012.
  10. ^ "Senior officials 'high earners' salaries as at 30 September 2015 – GOV.UK". gov.uk. 17 December 2015. Retrieved 9 March 2016.
  11. ^ "Dolly creator heads Scots honours". BBC News. 29 December 2007. Retrieved 25 August 2010.
  12. ^ "Honorary members | British Society for Immunology".
  13. ^ Minute Books of the Harveian Society. Library of the Royal College of Physicians of Edinburgh.
  14. ^ "29 new Fellows elected". AAHMS – Australian Academy of Health and Medical Sciences. 26 October 2021. Retrieved 29 October 2021.
Government offices
Preceded by CEO of the Medical Research Council Incumbent

Leave a Reply